Molecular characteristics of the Nipah virus glycoproteins

被引:23
|
作者
Diederich, Sandra [1 ]
Maister, Andrea [1 ]
机构
[1] Univ Marburg, Inst Virol, D-3550 Marburg, Germany
来源
BIOLOGY OF EMERGING VIRUSES: SARS, AVIAN AND HUMAN INFLUENZA, METAPNEUMOVIRUS, NIPAH, WEST NILE, AND ROSS RIVER VIRUS | 2007年 / 1102卷
关键词
Nipah virus; viral glycoproteins; G protein; fusion protein; proteolytic cleavage;
D O I
10.1196/annals.1408.003
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Nipah virus (NiV) is a highly pathogenic paramyxovirus, which emerged in 1998 from fruit bats in Malaysia and caused an outbreak of severe respiratory disease in pigs and fatal encephalitis in humans with high mortality rates. In contrast to most paramyxoviruses, NiV can infect a large variety of mammalian species. Due to this broad host range, its zoonotic potential, its high pathogenicity for humans, and the lack of effective vaccines or therapeutics, NiV was classified as a biosafety level 4 pathogen. This article provides an overview of the molecular characteristics of NiV focusing on the structure, functions, and unique biological properties of the two NiV surface glycoproteins, the receptor-binding G protein, and the fusion protein F. Since viral glycoproteins are major determinants for cell tropism and virus spread, a detailed knowledge of these proteins can help to understand the molecular basis of viral pathogenicity.
引用
收藏
页码:39 / 50
页数:12
相关论文
共 50 条
  • [31] Nipah virus encephalitis: MRI findings
    Anam, Ahmad Mursel
    Ahmad, Jamia
    Huq, Shihan Mahmud Redwanul
    Rabbani, Raihan
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2019, 49 (03) : 227 - 228
  • [32] Emerging trends of Nipah virus: A review
    Sharma, Vikrant
    Kaushik, Sulochana
    Kumar, Ramesh
    Yadav, Jaya Parkash
    Kaushik, Samander
    REVIEWS IN MEDICAL VIROLOGY, 2019, 29 (01)
  • [33] Nipah virus infection: current scenario
    Kulkarni, D. D.
    Tosh, C.
    Venkatesh, G.
    Kumar, D. Senthil
    INDIAN JOURNAL OF VIROLOGY, 2013, 24 (03): : 398 - 408
  • [34] The immune response to Nipah virus infection
    Joseph Prescott
    Emmie de Wit
    Heinz Feldmann
    Vincent J. Munster
    Archives of Virology, 2012, 157 : 1635 - 1641
  • [35] Nipah virus fusion protein: Influence of cleavage site mutations on the cleavability by cathepsin L, trypsin and furin
    Diederich, Sandra
    Dietzel, Erik
    Maisner, Andrea
    VIRUS RESEARCH, 2009, 145 (02) : 300 - 306
  • [36] Molecular biology of Hendra and Nipah viruses
    Wang, LF
    Harcourt, BH
    Yu, M
    Tamin, A
    Rota, PA
    Bellini, WJ
    Eaton, BT
    MICROBES AND INFECTION, 2001, 3 (04) : 279 - 287
  • [37] Efficacy of DNA immunization with F and G protein genes of Nipah virus
    Wang, Xijun
    Ge, Jinying
    Hu, Sen
    Wang, Qinghua
    Wen, Zhiyun
    Chen, Hualan
    Bu, Zhigao
    IMPACT OF EMERGING ZOONOTIC DISEASES ON ANIMAL HEALTH, 2006, 1081 : 243 - 245
  • [38] An mRNA-based reverse-vaccinology strategy to stimulate the immune response against Nipah virus in humans using fusion glycoproteins
    Naveed, Muhammad
    Mahmood, Sarmad
    Aziz, Tariq
    Arif, Muhammad Hammad
    Ali, Urooj
    Nouroz, Faisal
    Zacharis, Christos
    Alharbi, Metab
    Alshammari, Abdulrahman
    Alasmari, Abdullah F.
    ACTA BIOCHIMICA POLONICA, 2023, 70 (03) : 623 - 631
  • [39] Detailed Molecular Biochemistry for Novel Therapeutic Design Against Nipah and Hendra Virus: A Systematic Review
    Bhattacharya, Shreya
    Dhar, Shreyeshi
    Banerjee, Arundhati
    Ray, Sujay
    CURRENT MOLECULAR PHARMACOLOGY, 2020, 13 (02) : 108 - 125
  • [40] The emergence of Nipah virus, a highly pathogenic paramyxovirus
    Lo, Michael K.
    Rota, Paul A.
    JOURNAL OF CLINICAL VIROLOGY, 2008, 43 (04) : 396 - 400